Comparing the microbiota of the cystic fibrosis lung and human gut

Gut Microbes

Volumn 1, Issue 2, 2010, Pages 85-93

  Rogers, Geraint B ^a   Carroll, Mary P ^b   Hoffman, Lucas R ^c   Walker, Alan W ^d   Fine, David A ^b   Bruce, Kenneth D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Bacterial commuity profiling; Cystic fibrosis; Gut microbiota

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; COMPARATIVE STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; HUMAN; IMMUNE RESPONSE; INTESTINAL FIBROSIS; INTESTINE FLORA; LUNG LAVAGE; MICROBIAL COMMUNITY; MICROBIOLOGICAL EXAMINATION; MICROFLORA; MORTALITY; NONHUMAN; PATHOGENICITY; POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS);

EID: 77954857262     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.1.2.11350     Document Type: Article

References (143)

1. Rogers GB, Carroll MP, Bruce KD. Studying bacterial infections through culture-independent approaches. J Med Microbiol 2009; 58:1401-18.
2. Rogers GB, Stressmann FA, Walker AW, Carrroll MP, Bruce KD. Lung infections in cystic fibrosis; deriving clinical insight from microbial complexity. Exp Rev Mol Diagnostics 2010; In press.
3. Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Stremler N, Sarles J, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS ONE 2008; 3:2908.
4. Ecker DJ, Sampath R, Massire C, Blyn LB, Hall TA, Eshoo MW, et al. Ibis T5000: A universal biosensor approach for microbiology. Nat Rev Microbiol 2008; 6:553-8.
5. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004; 42:5176-83.
6. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 2008; 105:15070-5.
7. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Kehagia V, Jones GR, et al. Bacterial activity in cystic fibrosis lung infections. Respir Res 2005; 6:49.
8. Rogers GB, Stressmann FA, Koller G, Daniels T, Carroll MP, Bruce KD. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn Microbiol Infect Dis 2008; 62:133-41.
9. Rogers GB, Daniels TT, Tuck A, Carroll MP, Connett GJ, David GJ, et al. Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches. BMC Pulm Med 2009; 9:14.
10. Loux HR, Coplin WMV. Chronic phagedaena due to mixed infection. Ann Surg 1902; 35:586-97.
11. White GR. VIII, the identity of proteus infection and hospital gangrene: A case of mixed infection with Aerogenes capsulatus and Proteus vulgaris. Ann Surg 1902; 36:762-6.
12. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8.
13. Flint HJ, Duncan SH, Scott KP, Louis P. Interactions and competition within the microbial community of the human colon: Links between diet and health. Environ Microbiol 2007; 9:1101-11.
14. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65:4799-807.
15. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, et al. Real-time PCR in clinical microbiology: Applications for routine laboratory testing. Clin Microbiol Rev 2006; 19:165-256. www.landesbioscience.com
16. Feinstein LM, Sul WJ, Blackwood CB. Assessment of bias associated with incomplete extraction of microbial DNA from soil. Appl Environ Microbiol 2009; 75:5428-33.
17. McIlroy SJ, Porter K, Seviour RJ, Tillett D. Extracting nucleic acids from activated sludge which reflect community population diversity. Antonie Van Leeuwenhoek 2009; 96:593-605.
18. Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: Uses, limitations and future applications in acute-care settings. Lancet Infect Dis 2004; 4:337-48.
19. Clarridge JE, 3rd. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 2004; 17:840-62.
20. Juste A, Thomma BP, Lievens B. Recent advances in molecular techniques to study microbial communities in food-associated matrices and processes. Food Microbiol 2008; 25:745-61.
21. Malik S, Beer M, Megharaj M, Naidu R. The use of molecular techniques to characterize the microbial communities in contaminated soil and water. Environ Int 2008; 34:265-76.
22. Nocker A, Burr M, Camper AK. Genotypic microbial community profiling: A critical technical review. Microb Ecol 2007; 54:276-89.
23. Sontakke S, Cadenas MB, Maggi RG, Diniz PP, Breitschwerdt EB. Use of broad range16S rDNA PCR in clinical microbiology. J Microbiol Methods 2009; 76:217-25.
24. rd ed. London: Hodder Arnold 2007; 123-33.
25. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4:35-51.
26. Heijerman H. Infection and inflammation in cystic fibrosis: A short review. J Cyst Fibros 2005; 4:3-5.
27. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008; 177:995-1001.
28. Palmer KL, Aye LM, Whiteley M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 2007; 189:8079-87.
29. O'May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW. Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 2009; 58:765-73.
30. Rubin BK. Mucus, phlegm and sputum in cystic fibrosis. Respir Care 2009; 54:726-32.
31. Pedersen SS, Kharazmi A, Espersen F, Hoiby N. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun 1990; 58:3363-8.
32. Barth AL, Pitt TL. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 1996; 45:110-9.
33. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002; 109:317-25.
34. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: Relationships to cystic fibrosis pathogenesis. Dev Cell 2002; 3:593-603.
35. Fegan M, Francis P, Hayward AC, Fuerst JA. Heterogeneity, persistence and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients. J Clin Microbiol 1991; 29:2151-7.
36. Grothues D, Koopmann U, von der Hardt H, Tummler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988; 26:1973-7.
37. Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, et al. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS One 2009; 4:7370.
38. Bouchara JP, Hsieh HY, Croquefer S, Barton R, Marchais V, Pihet M, et al. Development of an oligo-nucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis. J Clin Microbiol 2009; 47:142-52.
39. Brockhurst MA, Buckling A, Gardner A. Cooperation peaks at intermediate disturbance. Curr Biol 2007; 17:761-5.
40. Harrison F, Browning LE, Vos M, Buckling A. Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biol 2006; 4:21.
41. Nadell CD, Xavier JB, Levin SA, Foster KR. The evolution of quorum sensing in bacterial biofilms. PLoS Biol 2008; 6:14.
42. Nadell CD, Xavier JB, Foster KR. The sociobiology of biofilms. FEMS Microbiol Rev 2009; 33:206-24.
43. Xavier JB, Foster KR. Cooperation and conflict in microbial biofilms. Proc Natl Acad Sci USA 2007; 104:876-81.
44. Jenkinson HF, Lamont RJ. Oral microbial communities in sickness and in health. Trends Microbiol 2005; 13:589-95.
45. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, et al. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 2008; 4:1000184.
46. Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104:13780-5.
47. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 2008; 24:4-10.
48. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-8.
49. Mai V, Morris JG Jr. Colonic bacterial flora: Changing understandings in the molecular age. J Nutr 2004; 134:459-64.
50. Zoetendal EG, Cheng B, Koike S, Mackie RI. Molecular microbial ecology of the gastrointestinal tract: From phylogeny to function. Curr Issues Intest Microbiol 2004; 5:31-47.
51. Jernberg C, Sullivan A, Edlund C, Jansson JK. Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Appl Environ Microbiol 2005; 71:501-6.
52. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1:56-66.
53. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, Rice LB. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J Microbiol Methods 2003; 54:249-56.
54. Green GL, Brostoff J, Hudspith B, Michael M, Mylonaki M, Rayment N, et al. Molecular characterization of the bacteria adherent to human colorectal mucosa. J Appl Microbiol 2006; 100:460-9.
55. Vanhoutte T, Huys G, Brandt E, Swings J. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 2004; 48:437-46.
56. Armougom F, Raoult D. Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans. BMC Genomics 2008; 9:576.
57. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:280.
58. Hoffmann C, Hill DA, Minkah N, Kirn T, Troy A, Artis D, et al. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun 2009; 77:4668-78.
59. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010; 4:232-41.
60. Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996; 273:1380-3.
61. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313:1126-30.
62. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003; 4:269-73.
63. Keilbaugh SA, Shin ME, Banchereau RF, McVay LD, Boyko N, Artis D, et al. Activation of RegIIIbeta/ gamma and interferon gamma expression in the intestinal tract of SCID mice: An innate response to bacterial colonisation of the gut. Gut 2005; 54:623-9.
64. Klaasen HL, Van der Heijden PJ, Stok W, Poelma FG, Koopman JP, Van den Brink ME, et al. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun 1993; 61:303-6.
65. Lopez-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 2000; 148:1305-15.
66. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006; 103:8487-92.
67. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via paneth cells. Proc Natl Acad Sci USA 2002; 99:15451-5.
68. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:280.
69. Wat D, Gelder C, Hibbitts S, Cafferty F, Bowler I, Pierrepoint M, et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008; 7:320-8.
70. Macfarlane S. Microbial biofilm communities in the gastrointestinal tract. J Clin Gastroenterol 2008; 42:142-3.
71. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57:677-701.
72. Fontaine L, Boutry C, Guedon E, Guillot A, Ibrahim M, Grossiord B, et al. Quorum-sensing regulation of the production of blp bacteriocins in Streptococcus thermophilus. J Bacteriol 2007; 189:7195-205.
73. Winstanley C, Fothergill JL. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett 2009; 290:1-9.
74. Tsou AM, Frey EM, Hsiao A, Liu Z, Zhu J. Coordinated regulation of virulence by quorum sensing and motility pathways during the initial stages of Vibrio cholerae infection. Commun Integr Biol 2008; 1:42-4.
75. Wu L, Holbrook C, Zaborina O, Ploplys E, Rocha F, Pelham D, et al. Pseudomonas aeruginosa expresses a lethal virulence determinant, the PA-I lectin/adhesin, in the intestinal tract of a stressed host: The role of epithelia cell contact and molecules of the quorum sensing signaling system. Ann Surg 2003; 238:754-64.
76. de Sablet T, Chassard C, Bernalier-Donadille A, Vareille M, Gobert AP, Martin C. Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 2009; 77:783-90.
77. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694-7.
78. Croswell A, Amir E, Teggatz P, Barman M, Salzman NH. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun 2009; 77:2741-53.
79. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77:2367-75.
80. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007; 1:56-66.
81. Macfarlane S, Dillon JF. Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol 2007; 102:1187-96.
82. Mandar R, Mikelsaar M. Transmission of mother's microflora to the newborn at birth. Biol Neonate 1996; 69:30-5.
83. Thompson-Chagoyan OC, Maldonado J, Gil A. Colonization and impact of disease and other factors on intestinal microbiota. Dig Dis Sci 2007; 52:2069-77.
84. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68:219-26.
85. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:177.
86. Trosvik P, Stenseth NC, Rudi K. Convergent temporal dynamics of the human infant gut microbiota. ISME J 2010; 4:151-8.
87. Hasegawa M, Osaka T, Tawaratsumida K, Yamazaki T, Tada H, Chen GY, et al. Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect Immun 2010; 78:639-50.
88. Martino DJ, Currie H, Taylor A, Conway P, Prescott SL. Relationship between early intestinal colonization, mucosal immunoglobulin A production and systemic immune development. Clin Exp Allergy 2008; 38:69-78.
89. Guarner F. Hygiene, microbial diversity and immune regulation. Curr Opin Gastroenterol 2007; 23:667-72.
90. Renders N, Verbrugh H, Van Belkum A. Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis. Infect Genet Evol 2001; 1:29-39.
91. Rogers GB, Carroll MP, Connett GJ, Serisier DJ, Hockey PM, Kehagia V, et al. Bacterial community diversity in the CF lung. Pediatric Pulmonology 2005; 40:95-7.
92. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007; 104:20529-33.
93. Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends Microbiol 2008; 16:107-14.
94. Hentges DJ. Enteric pathogen-normal flora interactions. Am J Clin Nutr 1970; 23:1451-6.
95. Freter R, Brickner H, Botney M, Cleven D, Aranki A. Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun 1983; 39:676-85.
96. Davidson JN, Hirsh DC. Use of the K88 antigen for in vivo bacterial competition with porcine strains of enteropathogenic Escherichia coli. Infect Immun 1975; 12:134-6.
97. Momose Y, Hirayama K, Itoh K. Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7. Antonie Van Leeuwenhoek 2008; 94:165-71.
98. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002; 51:448-54.
99. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2:204.
100. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-82.
101. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007; 5:2177-89.
102. Walk ST, Young VB. Emerging insights into antibiotic-associated diarrhea and Clostridium difficile infection through the lens of microbial ecology. Interdiscip Perspect Infect Dis 2008; 2008:125081.
103. CF Foundation. Patient registry annual data report 2007 (http://cff.org/UploadedFiles/research/ClinicalResearch/2007-patient-reg istry-report.pdf). 2007.
104. Machan ZA, Taylor GW, Pitt TL, Cole PJ, Wilson R. 2-heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother 1992; 30:615-23.
105. Hoffman LR, Deziel E, D'Argenio DA, Lepine F, Emerson J, McNamara S, et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 2006; 103:19890-5.
106. Miller MH, Edberg SC, Mandel LJ, Behar CF, Steigbigel NH. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob Agents Chemother 1980; 18:722-9.
107. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, et al. Small colony variants: A pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4:295-305.
108. Vanden Broeck D, Horvath C, De Wolf MJ. Vibrio cholerae: Cholera toxin. Int J Biochem Cell Biol 2007; 39:1771-5.
109. Yazdankhah SP, Caugant DA. Neisseria meningitidis: An overview of the carriage state. J Med Microbiol 2004; 53:821-32.
110. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, et al. Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous myco-bacteria II: Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167:835-40.
111. Voth DE, Ballard JD. Clostridium difficile toxins: Mechanism of action and role in disease. Clin Microbiol Rev 2005; 18:247-63.
112. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-31.
113. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009; 41:850-3.
114. Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3:417-27.
115. Lyte M. The microbial organ in the gut as a driver of homeostasis and disease. Med Hypotheses 2009; In press.
116. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun 2010; 24:9-16.
117. Mahony JB. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev 2008; 21:716-47.
118. Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, Halfvarson J, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009; 3:179-89.
119. Li F, Hullar MA, Schwarz Y, Lampe JW. Human gut bacterial communities are altered by addition of cruciferous vegetables to a controlled fruit- and vegetable-free diet. J Nutr 2009; 139:1685-91.
120. Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009; 96:557-67.
121. Lepage P, Colombet J, Marteau P, Sime-Ngando T, Dore J, Leclerc M. Dysbiosis in inflammatory bowel disease: A role for bacteriophages? Gut 2008; 57:424-5.
122. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998; 16:292-307.
123. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, Hoiby N, et al. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 2008; 190:2767-76.
124. Hollsing AE, Granstrom M, Vasil ML, Wretlind B, Strandvik B. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J Clin Microbiol 1987; 25:1868-74. www.landesbioscience.com
125. Mans JJ, von Lackum K, Dorsey C, Willis S, Wallet SM, Baker HV, et al. The degree of microbiome complexity influences the epithelial response to infection. BMC Genomics 2009; 10:380.
126. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 2008; 76:4163-75.
127. Gao Z, Tseng CH, Pei Z, Blaser MJ. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci USA 2007; 104:2927-32.
128. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, NISC Comparative Sequencing Program, et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324:1190-2.
129. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43:5721-32.
130. Nasidze I, Li J, Quinque D, Tang K, Stoneking M. Global diversity in the human salivary microbiome. Genome Res 2009; 19:636-43.
131. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8.
132. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-4.
133. Wilson M. Microbial Inhabitants of Humans: Their Ecology and Role in Health and Disease. Cambridge University Press 2005.
134. Kamei A, Koh AY, Gadjeva M, Priebe GP, Lory S, Pier GB. Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model. J Infect Dis 2010; 201:71-80.
135. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 2007; 30:7-15.
136. Rovery C, Greub G, Lepidi H, Casalta JP, Habib G, Collart F, et al. PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 2005; 43:163-7.
137. Bonnet R, Suau A, Dore J, Gibson GR, Collins MD. Differences in rDNA libraries of faecal bacteria derived from 10- and 25-cycle PCRs. Int J Syst Evol Microbiol 2002; 52:757-63.
138. Farrelly V, Rainey FA, Stackebrandt E. Effect of genome size and rrn gene copy number on PCR amplification of 16S rRNA genes from a mixture of bacterial species. Appl Environ Microbiol 1995; 61:2798-801.
139. Farris MH, Olson JB. Detection of Actinobacteria cultivated from environmental samples reveals bias in universal primers. Lett Appl Microbiol 2007; 45:376-81.
140. von Wintzingerode F, Gobel UB, Stackebrandt E. Determination of microbial diversity in environmental samples: Pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev 1997; 21:213-29.
141. Gomez-Alvarez V, Teal TK, Schmidt TM. Systematic artifacts in metagenomes from complex microbial communities. ISME J 2009; 3:1314-7.
142. Kunin V, Engelbrektson A, Ochman H, Hugenholtz P. Wrinkles in the rare biosphere: Pyrosequencing errors lead to artificial inflation of diversity estimates. Environ Microbiol 2010; 12:118-23.
143. Quince C, Lanzen A, Curtis TP, Davenport RJ, Hall N, Head IM, et al. Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods2009; 6:639-41.